CD4 and neoplasm: On the one hand, tumor-infiltrating neutrophils express a protein called PD1 ligand PDL1, which hinders the function of CD4+ and CD8+T cells by binding to PD1, and this interaction promotes the evasion of the immune system by the tumor (65–67).